Abstract
Dipotassium chlorazepate was administered to 12 healthy volunteers (8 males and 4 females), aged 22–38 years, as a single daily dose of 20 mg for 14 days. Plasma concentrations of N-desmethyldiazepam were monitored with a gas-chromatographic method during the medication period and for 5 days after withdrawal of the drug. The plasma half-life (t 1/2), the elimination coefficient (K β), the concentration (\(\bar C_{{\text{ss}}} \)), and the apparent volume of distribution (V β) were calculated at steady state, and the mean values±SEM were 53±6 h, 0.0147±0.0013 h-1, 884±73 ng/ml, and 1.13±0.08 l/kg, respectively. A moderate interindividual variability was observed regarding these parametes. There was no tendency toward a biexponential elimination. A significant difference in the apparent volume of distribution was found when males and females were compared.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arnold, E.: A simple method for determining diazepam and its major metabolites in biological fluids: application in bioavailability studies. Acta Pharmacol. Toxicol. 36, 335–352 (1975)
Berlin, A., Siewers, D., Agurell, S., Hiort, Å., Sjöqvist, F., Ström, S.: Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clin. Pharmacol. Ther. 13, 733–744 (1972)
Curry, S. H.: Drug disposition and pharmacokinetics, pp. 88–90. Oxford: Blackwell Scientific Publications 1974
Dasberg, H. H., van der Kleijn, E., Guelen, P. S. R., Praag, H. M. V.: Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin. Pharmacol. Ther. 15, 273–283 (1974)
Dasberg, H. H.: Oral diazepam in hospitalized anxiety patients (with observation on concentration-effect relationship). Pharmacopsych. 8, 162–169 (1975a)
Dasberg, H. H.: Effects and plasma levels of N-desmethyldiazepam after oral administration in normal volunteers. Psychopharmacologia (Berl.) 43, 191–198 (1975b)
Greaves, M. S.: Quantitative determination of medazepam, diazepam, and nitrazepam in whole blood by flame-ionization gas-liquid chromatography. Clin. Chem. 20, 141–147 (1974)
Hillestad, L., Hansen, T., Melsom, H., Drivenes, A.: Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular and oral administration. Clin. Pharmacol. Ther. 16, 479–484 (1974a)
Hillestad, L., Hansen, T., Melsom, H., Drivenes, A.: Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation. Clin. Pharmacol. Ther. 16, 485–489 (1974b)
Hoffman, D. J., Chun, A. H. C.: GLC determination of plasma drug levels after oral administration of chlorazepate potassium salts. J. Pharm. Sci. 64(10), 1668–1671 (1975)
Howard, A. G., Nickless, G.: A rapid gas-chromatographic method for the determination of diazepam and metabolites in body fluids. J. Chromatogr. 90, 325–329 (1974)
Kanto, J., Iisalo, E., Lethinen, V., Salminen, J.: The concentrations of diazepam and its metabolites in the plasma after an acute and chronic administration. Psychopharmacologia (Berl.) 36, 123–131 (1974)
Raveux, R., Gros, P.: Étude de l'excretion du chlorazépate dipotassique et de ses métabolites urinaires. III. Expérimentation chez l'homme aprés administrations en comprimes entériques et en gelules. Bull. chim. Ther. 4, 481–487 (1969)
Robin, A., Curry, S. H., Whelpton, R.: Clinical and biochemical comparison of chlorazepate and diazepam. Physiol. Med. 4, 388–392 (1974)
Sallé, J.: Expertise pharmacologique et toxicologique du chlorazepate dipotassique. Clin-Byla N.D.A.-file
de Silva, J. A. F., Foechlin, B. A., Bader, G.: Blood level distribution patterns of diazepam and its major metabolite in man. J. Pharm. Sci. 55, 692–702 (1966)
de Silva, J. A. F., Paglisi, C. V.: Determination of medazepam (Norbium), diazepam (Valium) and their major biotransformation products in blood and urine by electron capture gas-liquid chromatography. Analyt. Chem. 42, 1725–1736 (1970)
Tansella, M., Siciliani, O., Burti, I., Schiavon, M., Zimmermann, Tansella, Ch., Gerna, M., Tognoni, G., Morselli, P. L.: N-desmethyldiazepam and amylobartitone sodium as hypnotics in anxious patients, plasma levels, clinical efficacy an [residual effects. Psychopharmacologia (Berl.) 41, 81–85 (1975)
Tognoni, G., Gomeni, R., De Maio, D., Alberti, G. G., Franciosi, P., Scieghi, G.: Pharmacokinetics of N-desmethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Brit. J. clin. Pharmacol. 2, 227–232 (1975)
Wagner, J. G., Northam, J. I., Alway, C. D., Carpenter, O. S.: Blood levels of drug at the equilibrium state after multiple dosing. Nature (Lond.) 207, 1391–1402 (1965)
Zingales, I. A.: Diazepam metabolism during chronic medication unbound fraction in plasma, erythrocytes and uring. J. Chromatogr. 75, 55–78 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Post, C., Lindgren, S., Bertler, Å. et al. Pharmacokinetics of N-desmethyldiazepam in healthy volunteers after single daily doses of dipotassium chlorazepate. Psychopharmacology 53, 105–109 (1977). https://doi.org/10.1007/BF00426477
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00426477